The information in this section is intended for visitors outside the United States.
ALMOST $500 MILLION DONATED WORLDWIDE
In 2015, Gilead increased its global contributions by more than 60 percent, providing funds to nearly 2,000 nonprofit organizations that are widening access, reducing disparities and advancing education for healthcare professionals around the world.
379% INCREASE IN FUNDING FOR PREP PROGRAMS IN 2015
To help reduce the number of new HIV infections, Gilead gave $11 million to 101 community organizations that educate their members about the role of Pre-exposure Prophylaxis (PrEP) as part of comprehensive HIV prevention.
NEARLY 9 MILLION PEOPLE RECEIVING GILEAD HIV MEDICINES IN DEVELOPING COUNTRIES
Gilead’s tiered pricing and generic licensing model have enabled access to life-saving medicines for nearly nine million people in the developing world.
2.2 MILLION PEOPLE SCREENED FOR HIV AND 275,000 SCREENED FOR HCV
Gilead’s Frontlines of Communities in the United States (FOCUS) program addresses systemic and institutional barriers to routine HIV and HCV screening and access to care in 18 of the most vulnerable U.S. cities